|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
CTRI |
|
Last refreshed on:
|
29 April 2024 |
|
Main ID: |
CTRI/2024/04/066066 |
|
Date of registration:
|
22-04-2024 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Assessment of Cardiovascular outcomes in COVID-19 infected patients: A retrospective cohort study
|
|
Scientific title:
|
Assessment of Cardiovascular outcomes in COVID-19 infected patients - NIL |
|
Date of first enrolment:
|
01-05-2024 |
|
Target sample size:
|
212 |
|
Recruitment status: |
Not Yet Recruiting |
|
URL:
|
http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=94453 |
|
Study type:
|
Observational |
|
Study design:
|
Other Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Not Applicable Blinding and masking:Open Label
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
India
| | | | | | | |
|
Contacts
|
|
Name:
|
Prasanna Kumar
|
|
Address:
|
Manipal College of Pharmaceutical Sciences, Manipal, Karnataka , India
576104
Udupi, KARNATAKA
India |
|
Telephone:
|
9886725129 |
|
Email:
|
prasanna.shetty@manipal.edu |
|
Affiliation:
|
Manipal College of Pharmaceutical Sciences |
|
|
Name:
|
Vaishnavi Reghuprasad
|
|
Address:
|
Manipal College of Pharmaceutical Sciences, Manipal, Karnataka, India
576104
Udupi, KARNATAKA
India |
|
Telephone:
|
9886725129 |
|
Email:
|
prasanna.shetty@manipal.edu |
|
Affiliation:
|
Manipal College of Pharmaceutical Sciences |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Patients Above 18 Years or above are included in the study
Patients with confirmed positive SARS-CoV-2 test result and existing cardiovascular disease hospitalized between 1st January 2021 to 31st December 2022
Exclusion criteria: Incomplete patient data
Patients who experienced mortality within 24 hours of admission
Age minimum:
Age maximum:
Gender:
|
|
Health Condition(s) or Problem(s) studied
|
|
Health Condition 1: U071- COVID 19 virus identified
|
|
Intervention(s)
|
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
|
|
Primary Outcome(s)
|
|
To study the cardiovascular Hospitalization/Mortality in COVID 19 patientsTimepoint: 3 OCTOBER 2023 TO 5 JULY 2025
|
|
Secondary Outcome(s)
|
To assess the prevalence of Arterial thrombosis & venous thromboembolic events
To study the cardiovascular drug utilization
To study the drug interactionsTimepoint: 3 OCTOBER 2023 TO 5 JULY 2025
|
|
Source(s) of Monetary Support
|
|
Kasturba Hospital, Manipal, Karnataka, India
|
|
Ethics review
|
Status: Approved
Approval date: 26/09/2023
Contact:
Kasturba Medical College and Kasturba Hospital Institutional Ethics Committee -2
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|